Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 62 of the 125 sources its claims cite were checked for support.
Abstract
Iron deficiency (ID) is a critical public health issue globally and the most prevalent cause of anemia. Iron deficiency anemia (IDA) affects approximately 1.2 billion individuals worldwide, and it is estimated that non-anemic iron deficiency (NAID) is at least twice as common as IDA. Yet, there is still uncertainty about how to diagnose it in clinical practice. The serum ferritin (SF) threshold of <15 ng/mL proposed by the World Health Organization (WHO) has been questioned over the last decade. The current SF thresholds are inappropriately low, and, therefore, a large portion of the population at the most significant risk of ID remain undiagnosed and untreated. The correlation between SF, hepcidin, and the physiological upregulation of iron absorption in healthy adults suggests that SF of <50 ng/mL indicates a more precise threshold for diagnosing ID in adults. Therefore, adopting the SF threshold <50 ng/mL would break up the perpetuation of an inequitable cycle of disadvantage for ID individuals, especially among women.
Overview
CoChat Summary
TL;DR
This review argues that current serum ferritin (SF) thresholds for iron deficiency (ID), especially WHO’s <15 ng/mL, are inappropriately low and miss many affected individuals. It proposes adopting an SF threshold <50 ng/mL for adults, citing physiological evidence that iron absorption upregulation begins below approximately 50 ng/mL.
Key findings
- The WHO defines ID as SF <15 ng/mL (or <70 ng/mL with infection/inflammation), but the paper states this may overlook up to 50% of patients with ID, particularly premenopausal women.
- In a pooled analysis of stable iron isotope studies in healthy women (n = 1058), iron absorption increased below an SF threshold of 51.1 ng/mL and a hepcidin threshold of 3.09 nmol/L, supporting an SF cutoff of <50 ng/mL.
- In the EMPIRE study of 7980 adults in mainland Portugal, the proportion of IDA among anemic individuals varied by SF cutoff: 29.0% (<15 ng/mL), 54.8% (<30 ng/mL), 75.4% (<50 ng/mL), and 92.5% (<100 ng/mL).
- In the HEIRS cohort of 62,685 US and Canadian women, ID prevalence increased across definitions: 3.12% (SF <15 plus TSAT <10%), 7.43% (SF <15), and 15.33% (SF <25); among women aged 25–54, prevalence was 4.46%, 10.57%, and 21.23%, respectively.
Methods
- This is a narrative review/commentary; no formal methods section, systematic search strategy, or primary data collection is described.
- It synthesizes published evidence from cohort studies, meta-analyses, guidelines, and physiological studies, including data from HEIRS, NHANES, EMPIRE, blood donor studies, pregnancy studies, and surgical cohorts.
- The main analysis is a narrative synthesis of SF thresholds, hepcidin, iron absorption, and prevalence estimates across populations.
Limitations
- Stated: the paper notes that well-designed prospective clinical trials are crucial and that a recent WHO review highlighted the need for further investigation to establish a higher SF cutoff.
- Evident: as a narrative review, it does not use a systematic search or formal quality appraisal, and its recommendation of <50 ng/mL relies on selected studies and expert interpretation.
- Evident: the paper acknowledges concern that raising the cutoff would define nearly half of all females and approximately 14% of males as ID, but does not resolve potential overdiagnosis or resource implications with primary data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
44 Valid · 7 Not valid · 15 Not checked · 4 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“SF <15 ng/mL is a reliable indicator of absolute ID, irrespective of the presence or absence of inflammatory conditions [6,7,8,9,10].”
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 2. Serum Ferritin: A Biomarker of Iron Status That Requires Caution in Clinical Decisions
What the sources say
- Not matchedcites [6] World Health Organization (2020). WHO Guideline on Using Ferritin Concentrations to Assess Iron Status in Individuals and Populations, World Health Organization.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [7] Martens, 2023, Sex lies, and iron deficiency: A call to change ferritin reference range, Hematol. Am. Soc. Hematol. Educ. Program sourceExperimental — accuracy not yet measured
In “Why do we use ferritin as a measure of iron stores?” (page not specified), the paper calls ferritin a strong diagnostic test and explains that iron deficiency blunts its rise during inflammation. It does not establish the specific <15 ng/mL cutoff as reliable regardless of inflammatory status; it says the appropriate lower limit depends on the clinical scenario. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [8] Pasricha, 2018, Are current serum and plasma ferritin cut-offs for iron deficiency and overload accurate and reflecting iron status? A systematic review, Arch. Med Res. source
- Not checked — no full text of the sourcecites [9] Tang, 2022, Iron deficiency in women: Clearing the rust of silence, Lancet Haematol. source
- Partly supportedcites [10] Lemaire, B., Frias, M.A., Golaz, O., Magnin, J.-L., Viette, V., Vuilleumier, N., and Abramowski, S.W. (2024). Ferritin: A biomarker requiring caution in clinical decision. Diagnostics, 14. sourceExperimental — accuracy not yet measured
The Methods (section 2.4; page not provided) define iron deficiency as ferritin below 15 µg/L for the study cohort. But the Discussion (section 4; page not provided) says the cohort comprised healthy blood donors, calls for study in patients with inflammation, and notes that diagnostic thresholds vary with clinical status. The paper therefore does not establish that this cutoff is reliable irrespective of inflammation. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“At a steady state, the serum ferritin (SF) concentration reasonably reflects the total body iron stores.”
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 1. Introduction
What the sources say
- Supportedcites [3] Plays, 2021, Chemistry and biology of ferritin, Metallomics source
In “Ferritin as a prognostic factor,” the paper says serum ferritin is often used to estimate body iron content and can provide information on iron storage. Its caution that ferritin is not an absolute indicator is consistent with the claim’s qualified wording, “reasonably reflects.” (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [4] Muckenthaler, 2017, A Red carpet for iron metabolism, Cell source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The prevalence of ID significantly increased across definitions in the order of HEIRS (3.12%), WHO (7.43%), and IDE (15.33%).”
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 2. Serum Ferritin: A Biomarker of Iron Status That Requires Caution in Clinical Decisions
What the sources say
- Partly supportedcites [13] Barton, 2024, Prevalence of iron deficiency using 3 definitions among women in the US and Canada, JAMA Netw. Open sourceExperimental — accuracy not yet measured
The Results (General Characteristics of the Total Cohort; page not provided) report the three percentages for 62,685 women and state that they differed significantly, supporting the citing sentence. The supplied paraphrase adds “non-anemic,” which the paper cannot establish: its Limitations section says hemoglobin levels were unavailable. (LLM, conf=0.90)
plainstates a causen = 62,685 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“About 20–35% of European women in their reproductive ages had enough iron stores (SF concentration >70 ng/mL) to complete a pregnancy without supplementary iron [27].”
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 6. Non-Anemic Iron Deficiency: A Highly Prevalent Condition Among Pregnant Women
What the sources say
- Supportedcites [27] Milman, 2017, Iron status in pregnant women and women of reproductive age in Europe, Am. J. Clin. Nutr. source
The Abstract states that approximately 20–35% of European women of reproductive age had sufficient iron stores (SF >70 mg/L) to complete pregnancy without supplementary iron. The Conclusions clarify that this is an estimate and that prevalence outside Denmark was not known. The cited threshold in mg/L is equivalent to ng/mL. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For a normal pregnancy, the total iron needed is approximately 1000–1200 mg.”
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 6. Non-Anemic Iron Deficiency: A Highly Prevalent Condition Among Pregnant Women
What the sources say
- Partly supportedcites [25] Teichman, 2021, Suboptimal iron deficiency screening in pregnancy and the impact of socioeconomic status in a high-resource setting, Blood Adv. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says iron requirements increase during pregnancy, supporting the general premise. It does not give a total requirement of 1000–1200 mg; searches for that range and for total iron requirements found no such figure in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [26] Tang, 2024, Iron deficiency anemia among women: An issue of health equity, Blood Rev. source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
19 more claims · 16 with their cited sources checked
Create a free account to see all 70 claims and to verify the 4 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 38
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 8. Non-Anemic Iron Deficiency: A Prevalent Condition Among the Surgical Population
“In a large, multicenter cohort of major surgical procedures (n = 3342), the overall prevalence of anemia (Hb <130 g/L) was 36%, with differences according to the type of surgery. Iron status parameters were available for 2884 patients.”
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > References
“31. Spekman M.L.C. Ramondt S. Sweegers M.G. Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 9. Rethinking and Clearing the Rust of Silence About Iron Deficiency Diagnosis
“Laurent et al. [37] analyzed 29 guidelines published over the last decade.”
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > References
“37. Peyrin-Biroulet L. Williet N. Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: A systematic review”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 9. Rethinking and Clearing the Rust of Silence About Iron Deficiency Diagnosis
“absolute ID is defined by SF <100 ng/dL and TSAT <20%.”
§ Defining Global Thresholds for Serum Ferritin: A Challenging Mission in Establishing the Iron Deficiency Diagnosis in This Era of Striving for Health Equity > 5. The Lower Limit of Serum Ferritin for Defining Iron Deficiency: An Issue That Must Be Revised
“SF <100 ng/mL and TSAT <20% are the hallmarks of absolute ID”
Citations
Cites
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
A systematic analysis of global anemia burden from 1990 to 2010
Kassebaum, N. J., Jasrasaria, R., Naghavi, M., Wulf, S. K., Johns, N., Lozano, R., Regan, M., Weatherall, D., Chou, D. P., Eisele, T. P., et al. (2014) · Blood · doi:10.1182/blood-2013-06-508325 · Cited by 2,075
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Pasricha, S.-R., Tye-Din, J., Muckenthaler, M. U., & Swinkels, D. W. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32594-0 · Cited by 1,069
Camaschella, C. (2019) · Blood · doi:10.1182/blood-2018-05-815944 · Cited by 702
Laboratory diagnosis of iron-deficiency anemia: An overview
Guyatt, G. H., Oxman, A. D., Ali, M., Willan, A., McIlroy, W., & Patterson, C. (1992) · Journal of General Internal Medicine · doi:10.1007/bf02598003 · Cited by 564
Cappellini, M. D., Comin‐Colet, J., de Francisco, A., Dignass, A., Doehner, W., Lam, C. S., Macdougall, I. C., Rogler, G., Camaschella, C., Kadir, R., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24820 · Cited by 502
Hepcidin and Iron in Health and Disease
Nemeth, E., & Ganz, T. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-032816 · Cited by 457
Guidelines on the diagnosis and treatment of iron deficiency across indications: A systematic review
Peyrin-Biroulet, L., Williet, N., & Cacoub, P. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.103366 · Cited by 328
Cited by
Westesson, L. M., Elfvinge, P., Zetterberg, E., & Olsson, A. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.102949 · Cited by 10
“Ferritin levels 30 μ g/L were used for ID diagnosis in the present study [29,30].”
Iron Deficiency Diagnosis in Sub‐Saharan Africa: Challenges, Barriers, and Opportunities
Manu, B., Ofori, B., Kassim, A. R., Lamptey, E. L., Tandoh, K. Z., & Sarpong, K. A. N. (2026) · Anemia · doi:10.1155/anem/9089207 · Cited by 4
Su, H., An, H., Yang, J., et al. (2026) · Food Research International · doi:10.1016/j.foodres.2026.118367 · Cited by 2
Urrechaga, E., & Fernández, M. (2026) · Diagnostics · doi:10.3390/diagnostics16060928 · Cited by 1
“Conversely, in hospital or high-inflammation settings, raising the “rule-out” ferritin to 100 µ g/L improves sensitivity for iron deficiency, but with a marked loss of specificity, illustrating how inflammation pushes the useful diagnostic window upward [20–22].”
Xu, Y., Wu, X., Zhang, J., Niu, Q., Cai, B., & Miao, Q. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15030976 · Cited by 1
“Such RIs may underestimate physiological variability, particularly in peri-and postmenopausal women [10,11].”
Fujibayashi, M., Suganuma, A., Domichi, M., Hayashi, I., YAMAKATA, R., Fujikawa, H., Kumano, A., Kijima, K., Tomokane, S., Ogura, Y., et al. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.102906 · Cited by 1
Ferritin: Master Regulator of Iron Metabolism in Health and Disease
Ibe, O. E., Okorie, N., Abunimye, D. A., Ezaka, E. A., Ibekailo, S. N., Victor, C. C., Enyi, J. O., Oguji, C. E., Njar, V. E., & Igene, A. I. (2025) · Physiology · doi:10.5772/intechopen.1012713 · Cited by 2
Hov, G. G., Åsberg, A., Lian, I. A., Løfblad, L., Skjellegrind, H. K., & Mikkelsen, G. (2026) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2026.2725886
Iron Supplementation and Omega-3 Fatty Acids in Tuberculosis: Friend or Foe?
Wróblewski, M., Wróblewska, J., Długosz, A., & Mila-Kierzenkowska, C. (2026) · Biology · doi:10.3390/biology15141161
“In patients with inflammatory conditions, ferritin concentrations > 100 ng/mL together with TSAT 20% are generally considered indicative of anemia of inflammation [37].”
Li, Z., Ming, Q., Fu, L., Yang, J., Lv, Y., Chen, B., Qiu, X., & Lu, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1897378
Muñoz, M., Cabantchik, I. Z., Cançado, R. D., Evans, C., Girelli, D., Louw, V. J., Meybohm, P., Ozawa, S. J., Ozawa‐Morriello, J., Swinkels, D. W., et al. (2026) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000008217
Self-citationDiniz, C. A. S., de Souza, L. D., & Brum, H. C. C. (2026) · Research Society and Development · doi:10.33448/rsd-v15i7.51355 · Cited by 1
Singh, P., Singh, R. R., Uppal, M. S., et al. (2026) · National Journal of Medical Research · doi:10.55489/njmr.160320261364
“[13] Surgical Intervention and Stone Analysis: All patients underwent either laparoscopic or open cholecystectomy.”
Kosugi, M., Takezawa, R., Shiota, S., Inokuchi, S., Takaya, H., & Yamauchi, M. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-03057-4 · Cited by 1
Zeidan, R. S., Yang, J. J., He, R., Cenko, E., Mohr, A. M., Picca, A., Anton, S. D., & Cacciatore, S. (2026) · Nutrients · doi:10.3390/nu18101522
Maynard, S., Drakesmith, C. W., Smith, M. C., Haynes, S., Katumba, A. M., Maharajan, V., Maurer, K., Erone, I., Shah, A., Nigam, G. B., et al. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100070
Metadata
- Authors
- Cancado, R. D., Leite, L. A. C., & Muñoz, M.
- Affiliations
- Department of Hematology, Faculdade de Ciências Médicas da Santa Casa de Sao Paulo, Sao Paulo 01224-001, Brazil
- Hospital Samaritano de São Paulo (BR)
- Peri-Operative Transfusion Medicine, School of Medicine, 29010 Malaga, Spain
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2025-01-26
- Volume
- 15
- Issue
- 3
- Pages
- 289
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC11817370
- OpenAlex
- W4406874221
- Cited by
- 19
- References
- 38
- Citations by year
- 2026: 17 · 2025: 2
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- CSL Vifor
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- iron deficiency, serum ferritin, diagnostic thresholds, iron deficiency anemia, non-anemic iron deficiency, hepcidin, iron absorption, health equity, women's health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.